Skip to main content

Naltrexone News

Rapid Procedure Noninferior for Extended-Release Naltrexone Initiation

THURSDAY, May 9, 2024 – For patients with opioid use disorder (OUD), a rapid procedure (RP) is noninferior to a standard procedure for initiation of extended-release (XR) naltrexone, according to a...

Rural Americans Are Going Without Meds to Fight Opioid, Alcohol Addictions

TUESDAY, March 26, 2024 — Less than 9% of rural Americans who abuse both opioids and alcohol are prescribed medications to treat both disorders, new research reveals. Naltrexone treats both opioid u...

FDA Medwatch Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing

ISSUE: FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information....

FDA Approves Contrave (bupropion/naltrexone) for Weight Management

September 10, 2014 – The U.S. Food and Drug Administration today approved Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) as treatment option for chronic...

FDA Approves Vivitrol to Treat Opioid-dependent Patients

ROCKVILLE, Md., Oct. 12, 2010--The U.S. Food and Drug Administration today approved Vivitrol to treat and prevent relapse after patients with opioid dependence have undergone detoxification...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Alcohol Dependence, Fibromyalgia, Smoking Cessation, Opiate Dependence

Related drug support groups

Vivitrol

Naltrexone patient information at Drugs.com